4//SEC Filing
BOBO DONALD E JR 4
Accession 0001225208-26-000378
CIK 0001099800other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:02 PM ET
Size
12.2 KB
Accession
0001225208-26-000378
Insider Transaction Report
Form 4
BOBO DONALD E JR
CVP,Strategy/Corp Development
Transactions
- Exercise/Conversion
Common Stock
2026-01-06$59.26/sh+11,340$671,971→ 43,210.253 total - Sale
Common Stock
2026-01-06$84.62/sh−2,632$222,721→ 40,578.253 total - Sale
Common Stock
2026-01-06$85.98/sh−8,708$748,708→ 31,870.253 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2026-01-06−11,340→ 34,020 totalExercise: $59.26From: 2019-06-08Exp: 2026-05-07→ Common Stock (11,340 underlying)
Holdings
- 38,817.699(indirect: By 401(k))
Common Stock
- 135,152(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $84.39 to $85.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $85.40 to $86.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001196661
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:02 PM ET
- Size
- 12.2 KB